June 17, 2026 | Korea Sets the Stage for BIO 2026

Issue #40 · June 17

View Archive | Subscribe | Partners With Us

From Members to Global: Covering the Entire Bio Industry

With BIO 2026 just days away, it's time to spotlight the Korean companies set to take the global stage 🌟

From global ambitions and regulatory shifts to anti-aging therapies and next-generation innovation, here's what made it into this week's newsletter.

Stay tuned till the end for more K-Bio updates!

EDITOR'S NOTE

🤝 Meet Korea at BIO 2026 🇰🇷

In less than a week, the global biotech community will gather in San Diego for BIO 2026!

KoreaBIO is preparing a dynamic lineup of programs to connect Korean biotech innovators with global partners and showcase Korea's growing biotech ecosystem.

📍 KEY PROGRAM SCHEDULE HIGHLIGHTS

✨ For detailed schedules and program info, please visit our website.

We look forward to seeing you next week 👀

THIS WEEK:

K-Bio Debuts Official Session at Bio USA

In particular, an official session themed on the Korean biotech industry has been prepared for this event. — Businesskorea

U.S. Congress Accelerates Biosimilar Regulatory Easing... "K-Bio Companies Expected to Benefit" As the U.S. Congress accelerates regulatory easing for biosimilars, it is expected that the pace of local market entry for K-bio companies will increase and they will benefit as a result. — The Asia Business Daily

K-Bio Targets $170 Billion Latin America, Southeast Asia Pharmerging Markets Korean pharmaceutical and biotech companies are accelerating their push into "pharmerging markets" such as Southeast Asia and Latin America as next-generation export hubs. — Seoul Economic Daily

KoreaBIO MEMBER NEWS

#Members_Only

#New #Welcome

2026 2nd CEO Golf Affinity ⛳ | June 11

Members-only networking program fostering collaboration among KoreaBIO member CEOs!

Welcome on board! 💼

Pluto Labs is joining us as a new member company specializing in an AI-based R&D Intelligence platform.

C&R Research, Wins U.S. Clinical Trial Contract for Korea’s First Approved Digital Therapeutic "Somzz".

Oscotec to Participate in BIO International Convention 2026 and Showcase Next-Generation Pipeline.

Crescom Initiates Global Musculoskeletal AI Validation Project with MGB Hospital Network.

NexThera Completes First Patient Enrollment in Part 2 of U.S. Phase 1/2a Trial for Wet AMD Therapy NT-101.

MicroDigital Wins Best Prize at WFT26 and Expands Food Tech Presence.

Neurophet Expands Subscription-Based Business with Selection by Three Regional Hub Hospitals.

XCELL Therapeutics Advances PMDA MF Registration for Medipost’s Japan Market Entry and Commercialization.

👥 View More Members Companies

Here's what's happening across Korea's bio industry!

WHAT'S HAPPENING

KOREA GOES GLOBAL

∎ Japan, South Korea challenge the West’s place in research rankings: report - Fierce Biotech
∎ Kolon Life Science Secures Singapore Patent for TG-C Osteoarthritis Treatment - Seoul Economic Daily
∎ Samil Pharmaceutical signs Vietnam licensing deal for postoperative eye drop - KBR
∎ SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development - The Korea Herald
∎ ROKIT to launch what it calls 1st human kidney regeneration surgery in July - KBR

INNOVATION & TRENDS

∎ Crescom launches Mass General Brigham validation study for pediatric imaging AI - KBR
∎ ToolGen Establishes Osong Gene-Edited Crop Demonstration Field - The Asia Business Daily
∎ Anti-aging race intensifies as Korea and U.S. push rejuvenation therapies - Chosun Biz
∎ One New Drug Targets Multiple Diseases... Pharma and Biotech Accelerate "Indication Diversification" - The Asia Business Daily
∎ US, EU cut animal tests as AI and organ models rise, spurring Korea response - Chosun Biz

GROWTH & PERFORMANCE

∎ Yuhan’s Lesigercept Shows Sustained IgE Suppression in Phase 1b Study - Hit News
∎ Lotte Biologics Completes Production Facility in Songdo, Boosting Capacity to 160,000 Liters - Aju Press
∎ Gov't to supply clinical-grade stem cells to speed up biotech breakthroughs - The Korea Times

∎ Korea Biotechnology Industry Organization Nurtures ‘Gyeonggi-do Bio Big Data Talent’ to Lead the AI Era in Pangyo - AVING NEWS

📰 View Lastest KoreaBIO News

🧬 Road to BIO 2026 🌐

KoreaBIO to Join BIO USA with 51 Companies Participating

Korea Biotechnology Industry Organization announced on June 16 that it will participate in “BIO International Convention 2026,” which will be held in San Diego, USA, starting from June 22.

→ Read the full story

Korean drugmakers target licensing, CDMO deals at BIO USA 2026

For Korean companies, the event has increasingly become a venue for licensing negotiations, manufacturing contracts and strategic partnerships rather than a traditional exhibition.

→ Read the full story